Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiaming Zhou

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Angewandte Chemie (International Ed. in English)|September 21, 2024
Visualizing Triplet Energy Transfer in Organic Near-Infrared Phosphorescent Host-Guest MaterialsZihao Deng, Fan-Cheng Kong, Ziqi Deng, et al.
Science Advances|August 1, 2025
Flexoelectric manipulation of ferroelectric polarization in self-strained telluriumYan Yan, Xiongyi Liang, Liqiang Wang, et al.
The Oncologist|January 5, 2021
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II TrialHuabin Hu, Kun Wang, Meijin Huang, et al.
The Lancet. Gastroenterology & Hepatology|October 24, 2021
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trialHuabin Hu, Liang Kang, Jianwei Zhang, et al.
Med (New York, N.Y.)|May 14, 2026
Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2)Jianwei Zhang, Sifan Qi, Huabin Hu, et al.
The Lancet. Oncology|July 1, 2026
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trialHuabin Hu, Xutao Shen, Yunfeng Li, et al.
Frontiers in Oncology|March 11, 2022
Deep Learning-Based Classification of Cancer Cell in Leptomeningeal Metastasis on Cytomorphologic Features of Cerebrospinal FluidWenjin Yu, Yangyang Liu, Yunsong Zhao, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Angewandte Chemie (International Ed. in English)|September 21, 2024
Visualizing Triplet Energy Transfer in Organic Near-Infrared Phosphorescent Host-Guest MaterialsZihao Deng, Fan-Cheng Kong, Ziqi Deng, et al.
Science Advances|August 1, 2025
Flexoelectric manipulation of ferroelectric polarization in self-strained telluriumYan Yan, Xiongyi Liang, Liqiang Wang, et al.
The Oncologist|January 5, 2021
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II TrialHuabin Hu, Kun Wang, Meijin Huang, et al.
The Lancet. Gastroenterology & Hepatology|October 24, 2021
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trialHuabin Hu, Liang Kang, Jianwei Zhang, et al.
Med (New York, N.Y.)|May 14, 2026
Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2)Jianwei Zhang, Sifan Qi, Huabin Hu, et al.
The Lancet. Oncology|July 1, 2026
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trialHuabin Hu, Xutao Shen, Yunfeng Li, et al.
Frontiers in Oncology|March 11, 2022
Deep Learning-Based Classification of Cancer Cell in Leptomeningeal Metastasis on Cytomorphologic Features of Cerebrospinal FluidWenjin Yu, Yangyang Liu, Yunsong Zhao, et al.
Pageof 13